McKesson EBITDA 2010-2024 | MCK

McKesson EBITDA for the quarter ending June 30, 2024 was $1.198B, a 4.85% decline year-over-year.

  • McKesson 2024 EBITDA was 4.544B, a 8.92% decline from 2023.
  • McKesson 2023 EBITDA was 4.989B, a 78.31% increase from 2022.
  • McKesson 2022 EBITDA was 2.798B, a 171.54% decline from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

McKesson EBITDA 2010-2024 | MCK

  • McKesson 2024 EBITDA was 4.544B, a 8.92% decline from 2023.
  • McKesson 2023 EBITDA was 4.989B, a 78.31% increase from 2022.
  • McKesson 2022 EBITDA was 2.798B, a 171.54% decline from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Becton Dickinson (BDX)$69.4B
Cardinal Health (CAH)$28B
West Pharmaceutical Services (WST)$23.9B
Cooper (COO)$20.7B
Labcorp (LH)$19.6B
Align Technology (ALGN)$16.8B
Henry Schein (HSIC)$8.9B
Merit Medical Systems (MMSI)$6B
DENTSPLY SIRONA (XRAY)$4.9B
CONMED (CNMD)$2.3B
Patterson (PDCO)$1.9B
STAAR Surgical (STAA)$1.5B
Lifevantage (LFVN)$175M
Pro-Dex (PDEX)$140M